Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors-Reference-Cited by-同舟云学术

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors

Published:2022-07-05 Issue:7 Volume:12 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Vassilakopoulos Theodoros P.^ORCID,Kravvariti Evrydiki,Panitsas Fotios^ORCID,Angelopoulou Maria K.,Liaskas Athanasios,Kontopidou Flora N.,Yiakoumis Xanthoula,Variami Eleni,Dimopoulou Maria N.,Siakantaris Marina P.,Asimakopoulos John V.,Arapaki Maria,Dimou Maria^ORCID,Diamantopoulos Panagiotis^ORCID,Sachanas Sotirios,Chatzidimitriou Chrysovalantou,Belia Marina,Konstantinou Elianna,Boutsikas George,Petevi Kyriaki,Kanellopoulos Alexandros^ORCID,Kokoris Styliani,Kyrtsonis Marie-Christine,Viniou Nora-Athina,Lakiotaki Eleftheria,Tsourouflis Gerasimos,Korkolopoulou Penelope,Konstantopoulos Kostas,Panayiotidis Panayiotis,Pangalis Gerassimos A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://www.nature.com/articles/s41408-022-00674-w.pdf

Reference15 articles.

1. Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH, et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin’s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;385:1853–62.

2. Hapgood G, Zheng Y, Sehn LH, Villa D, Klasa R, Gerrie AS, et al. Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia. J Clin Oncol. 2016;34:2493–500.

3. Herman TS, Hoppe RT, Donaldson SS, Cox RS, Rosenberg SA, Kaplan HS. Late relapse among patients treated for Hodgkin’s disease. Ann Intern Med. 1985;102:292–7.

4. Bodis S, Henry-Amar M, Bosq J, Burgers JM, Mellink WA, Dietrich PY, et al. Late relapse in early-stage Hodgkin’s disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. J Clin Oncol. 1993;11:225–32.

5. Brierley JD, Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Pintillie M. Late relapse after treatment for clinical stage I and II Hodgkin’s disease. Cancer. 1997;79:1422–7.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Classification by Intent in Oncology—The Need for Meaningful Definitions: Curative, Palliative and Potentially Life-Prolonging;Journal of Personalized Medicine;2024-08-31

2. Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study;HemaSphere;2024-07

3. H10: Long-Term Results Could Be Misleading Without an Updated Reading Key for Positron Emission Tomography;Journal of Clinical Oncology;2024-06-20

4. Harnessing multi-source data for individualized care in Hodgkin Lymphoma;Blood Reviews;2024-05

5. Correlating Time Series Analysis with Radiotherapy for the Early Detection of Hodkin Lymphoma;2024 International Conference on Optimization Computing and Wireless Communication (ICOCWC);2024-01-29